Aspiriant LLC’s Investors Title Co ITIC Stock Holding History

Aspiriant LLC’s Portfolio ITIC Stock Details ITIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,185	Closed	-$1.31M	–	282
2021 Q3	$1.31M	Buy	+7,185	New	+$1.29M	0.08%	101

Other funds holding ITIC

Markel Group Glen Allen, Virginia $11.9B AUM 10.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aspiriant LLC's ITIC Position: Q4 2021 in Review

Aspiriant LLC sold out of Investors Title Co (ITIC) in Q4 2021, closing a stake of 7,185 shares — an estimated $1.31M sold.

Aspiriant LLC first reported a position in ITIC in Q3 2021 and held it in 1 quarter. The position peaked at $1.31M in Q3 2021. 77 funds tracked by Wall St. Rank hold ITIC as of Q4 2021.

Aspiriant LLC reported no remaining Investors Title Co position as of Q4 2021 after selling out during the quarter.
Aspiriant LLC sold 7,185 Investors Title Co shares in Q4 2021, an estimated $1.31M.
Aspiriant LLC first reported a position in Investors Title Co in Q3 2021 and held it in 1 quarter.
Aspiriant LLC's Investors Title Co position peaked at $1.31M in Q3 2021.
77 funds tracked by Wall St. Rank held Investors Title Co as of Q4 2021.

Based on Aspiriant LLC's 13F filing for Q4 2021, filed 14 Feb 2022.